Obesitas Sebagai Faktor Risiko Keparahan Pada COVID-19
Keywords:
Obesitas, keparahan, COVID-19Abstract
Obesitas diketahui sebagai peradangan kronis derajat rendah. Hal ini menjadi faktor yang dapat menyebabkan keparahan pada gejala COVID-19. Gejala COVID-19 dinyatakan dalam asimptomatis hingga kritis dan obesitas dicurigai memiliki peran dalam tingkat keparahan COVID-19. Tujuan penelitian ini adalah untuk mengetahui hubungan antara obesitas dengan tingkat keparahan COVID-19. Penelitian ini dilakukan pada 13 Desember 2020 pada mesin pencarian Pubmed, Science Direct dan Google Scholar dengan memasukkan kata kunci (obesity OR overweight) AND risk factor AND (severe OR severity) AND fatality rate AND (COVID-19 OR SARS-CoV-2 OR Novel coronavirus). Selanjutnya dilakukan skrining sesuai dengan kriteria restriksi yang telah ditetapkan dan mengelompokkan artikel penelitian dalam tabel lalu diurutkan sesuai alphabet nama peneliti. Data yang sudah terkumpul selanjutnya dilakukan penarikan kesimpulan, sehingga didapatkan sampel sebanyak 11 artikel berasal dari Negara Italia, China, New York, USA dan Prancis. Berdasarkan hasil penelitian didapatkan adanya hubungan antara BMI dan nilai risiko yang menyebabkan keparahan pada COVID-19. Semakin tinggi kenaikan angka BMI akan memberikan nilai risiko yang lebih tinggi pula. Keparahan penyakit ditandai dengan penggunaan alat bantu pernafasan (IMV, NIV, oksigenasi dan ECMO), penggunaan ruang ICU, penurunan PaO2 dan SaO2 serta hipoksemia.
References
2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.
3. Zhou P, Yang X Lou, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature [Internet]. 2020;579(7798):270–3. Available from: http://dx.doi.org/10.1038/s41586-020-2012-7
4. WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard. [cited 2020 Nov 13]. Available from: https://covid19.who.int/
5. Beranda | Satgas Penanganan COVID-19. [cited 2020 Nov 13]. Available from: https://covid19.go.id/
6. Yang J, Zheng Y, Gou X, Pu K, Chen Z. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2. Int J Infect Dis. 2020;94(April):91–5.
7. Obesity and overweight. 2017 [cited 2020 Nov 9]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
8. Cardone M, Yano M, Rosenberg AS, Puig M. Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation. Front Immunol. 2020;11(May).
9. Salvator H, Grassin-Delyle S, Naline E, Brollo M, Fournier C, Couderc LJ, et al. Contrasting Effects of Adipokines on the Cytokine Production by Primary Human Bronchial Epithelial Cells: Inhibitory Effects of Adiponectin. Front Pharmacol. 2020;11(February):1–9.
10. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
11. Richard C, Wadowski M, Goruk S, Cameron L, Sharma AM, Field CJ. Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy. BMJ Open Diabetes Res Care. 2017;5(1):1–10.
12. Foncea HZ, Francaux M, Deldicque L, Hawley JA. Does High Cardiorespiratory Fitness Confer Some Protection Against Proinflammatory Responses After Infection by SARS-CoV-2? Obesity. 2020;28(8):1378–81.
13. Rezende LFM, Thome B, Schveitzer MC, de Souza-Júnior PRB, Szwarcwald CL. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil. Rev Saude Publica. 2020;54(June).
14. Busetto L, Bettini S, Fabris R, Serra R, Dal Pra C, Maffei P, et al. Obesity and COVID-19: An Italian Snapshot. Obesity. 2020;28(9):1600–5.
15. Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care. 2020;43(7):1392–8.
16. Cai SH, Liao W, Chen SW, Liu LL, Liu SY, Zheng ZD. Association between obesity and clinical prognosis in patients infected with SARS-CoV-2. Infect Dis Poverty. 2020;9(1):5–11.
17. Hajifathalian K, Kumar S, Newberry C, Shah S, Fortune B, Krisko T, et al. Obesity is Associated with Worse Outcomes in COVID-19: Analysis of Early Data from New York City. Obesity. 2020;28(9):1606–12.
18. Kalligeros M, Shehadeh F, Mylona EK, Benitez G, Beckwith CG, Chan PA, et al. Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019. Obesity [Internet]. 2020;28(7):1200–4. Available from: doi:10.1002/oby.22859
19. Moriconi D, Masi S, Rebelos E, Virdis A, Laura M, Marco S De, et al. Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding Diego. 2020;(January). Available from: http://doi.org/10.1016/j.orcp.2020.05.009
20. Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. Severe obesity is associated with higher in-hospital mortality in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108(May).
21. Pettit NN, MacKenzie EL, Ridgway JP, Pursell K, Ash D, Patel B, et al. Obesity is Associated with Increased Risk for Mortality Among Hospitalized Patients with COVID-19. Obesity. 2020;28(10):1806–10.
22. Rottoli M, Bernante P, Belvedere A, Balsamo F, Garelli S, Giannella M, et al. How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre. Vol. 183, European Journal of Endocrinology. 2020. 389–397 p.
23. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation.Obesity.2020;28(7):1195–9.
24. Zhu Z, Hasegawa K, Ma B, Fujiogi M. Association of obesity and its genetic predisposition with the risk of severe COVID-19: Analysis of population-based cohort data. Metab Cliniical Exp [Internet]. 2020;(January). Available from: https://doi.org/10.1016/j.metabol.2020.154345
25. Hellman U, Karlsson MG, Engström-Laurent A, Cajander S, Dorofte L, Ahlm C, et al. Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options? J Biol Chem. 2020;295(45):15418–22.
26. Ontong P, Prachayasittikul V. Unraveled roles of hyaluronan in severe COVID-19. EXCLI J. 2021;20:117–25.
27. Tamara A, Tahapary DL. Obesity as a predictor for a poor prognosis of COVID-19: A systematic review. Diabetes Metab Syndr Clin Res Rev. 2020;14(January):655–9.
28. Zhang X, Li S, Niu S. ACE2 and COVID-19 and the resulting ARDS. Postgrad Med J. 2020;403–7.
29. Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol [Internet]. 2020;92(4):424–32. Available from: http://dx.doi.org/10.1002/jmv.25685
30. De Jong A, Verzilli D, Jaber S. ARDS in Obese Patients: Specificities and Management. Crit Care. 2019;23(1).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Nadia Wdihi Aqmarina, Erika Diana Risanti, Iin Novita Nurhidayati Mahmudah, Safari Wahyu Jatmiko
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
